Abstract

Objectives: Progestin-only pills (POPs) prevent pregnancy through a combination of mechanisms including ovarian suppression and cervical mucus changes. In this study, we sought to evaluate the potential contraceptive efficacy of a norgestrel 75 mcg POP based on cervical mucus and ovulatory effect changes during a 28 day cycle.

Highlights

  • With a panel of experts, we developed a prototype over-the-counter (OTC) Drug Facts Label (DFL) for a combined oral contraception (COC) 0.1mg levonorgestrel/0.02mg ethinyl estradiol pill

  • Eleven primary communication messages were developed based on an assessment of the clinical risks that are likely if consumers fail to heed key communication messages on the DFL, and included those that, if not heeded, represent the greatest potential for clinical consequence to consumers

  • After reading the prototype OTC COC label, 10 of the 11 primary communication messages were each understood by ≥95% of participants, and the remaining message was understood by 88% of participants; 99% of participants correctly understood what the product was used for

Read more

Summary

Objectives

Current approaches rely on imaging studies or invasive exploratory exams to confirm a copper intrauterine device (Cu-IUD) when strings are missing. Our study objective was to determine whether Cu levels in cervical mucus could be used to discriminate between Cu-IUD users and nonusers. We collected cervical mucus at any time in the menstrual cycle as well as subject and Cu-IUD usage characteristics. Using inductively coupled plasma mass spectrometry (ICPMS), we determined the concentration of Cu in cervical mucus samples and compared Cu levels between Cu-IUD users and non-users. We found higher Cu levels in the cervical mucus of Cu-IUD users compared to nonusers (mean Cu concentration 2.80 μg/g vs 0.33 μg/g, p

Findings

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.